These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7583141)

  • 1. Transcriptional regulation. Flipping the Myc switch.
    Bernards R
    Curr Biol; 1995 Aug; 5(8):859-61. PubMed ID: 7583141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sin3 corepressor function in Myc-induced transcription and transformation.
    Harper SE; Qiu Y; Sharp PA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8536-40. PubMed ID: 8710905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
    Hurlin PJ; Quéva C; Koskinen PJ; Steingrímsson E; Ayer DE; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1995 Nov; 14(22):5646-59. PubMed ID: 8521822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3.
    Ayer DE; Lawrence QA; Eisenman RN
    Cell; 1995 Mar; 80(5):767-76. PubMed ID: 7889570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3.
    Schreiber-Agus N; Chin L; Chen K; Torres R; Rao G; Guida P; Skoultchi AI; DePinho RA
    Cell; 1995 Mar; 80(5):777-86. PubMed ID: 7889571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes.
    Hurlin PJ; Ayer DE; Grandori C; Eisenman RN
    Cold Spring Harb Symp Quant Biol; 1994; 59():109-16. PubMed ID: 7587059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic in vivo interactions among Myc network members.
    Yin X; Landay MF; Han W; Levitan ES; Watkins SC; Levenson RM; Farkas DL; Prochownik EV
    Oncogene; 2001 Aug; 20(34):4650-64. PubMed ID: 11498788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor.
    Meroni G; Reymond A; Alcalay M; Borsani G; Tanigami A; Tonlorenzi R; Lo Nigro C; Messali S; Zollo M; Ledbetter DH; Brent R; Ballabio A; Carrozzo R
    EMBO J; 1997 May; 16(10):2892-906. PubMed ID: 9184233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression by the Mad(Mxi1)-Sin3 complex.
    Schreiber-Agus N; DePinho RA
    Bioessays; 1998 Oct; 20(10):808-18. PubMed ID: 9819568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional control: calling in histone deacetylase.
    Kiermaier A; Eilers M
    Curr Biol; 1997 Aug; 7(8):R505-7. PubMed ID: 9259549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites.
    Hurlin PJ; Quéva C; Eisenman RN
    Genes Dev; 1997 Jan; 11(1):44-58. PubMed ID: 9000049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.
    Ayer DE; Kretzner L; Eisenman RN
    Cell; 1993 Jan; 72(2):211-22. PubMed ID: 8425218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A biochemical and biological analysis of Myc superfamily interactions.
    Schreiber-Agus N; Alland L; Muhle R; Goltz J; Chen K; Stevens L; Stein D; DePinho RA
    Curr Top Microbiol Immunol; 1997; 224():159-68. PubMed ID: 9308239
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural aspects of interactions within the Myc/Max/Mad network.
    Nair SK; Burley SK
    Curr Top Microbiol Immunol; 2006; 302():123-43. PubMed ID: 16620027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.
    Nair SK; Burley SK
    Cell; 2003 Jan; 112(2):193-205. PubMed ID: 12553908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
    J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
    James L; Eisenman RN
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
    Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B; Larsson LG
    Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.